Your browser doesn't support javascript.
loading
Angioimmunoblastic T-cell lymphoma associated with immune checkpoint inhibitor treatment.
Duke, Taylor C; Nair, Ranjit; Torres-Cabala, Carlos; Amaria, Rodabe N; Keiser, Elizabeth; Miranda, Roberto; Iyer, Swaminathan P; Heberton, Meghan.
Afiliación
  • Duke TC; Department of Dermatology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas.
  • Nair R; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Torres-Cabala C; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Amaria RN; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Keiser E; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Miranda R; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Iyer SP; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Heberton M; Department of Dermatology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas.
JAAD Case Rep ; 6(12): 1264-1267, 2020 Dec.
Article en En | MEDLINE | ID: mdl-33294560
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: JAAD Case Rep Año: 2020 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: JAAD Case Rep Año: 2020 Tipo del documento: Article